Insider Trading Activity Repligen (NASDAQ:RGEN) – Major Shareholder Sold 118,850 shares of Stock

ME Staff
-
0

Insider Trading Activity For Repligen (NASDAQ:RGEN)

Roy T Eddleman , Major Shareholder of Repligen (NASDAQ:RGEN) reportedly Sold 118,850 shares of the company’s stock at an average price of 42.07 for a total transaction amount of $5,000,019.50 SEC Form

Insider Trading History For Repligen (NASDAQ:RGEN)

  • On 8/16/2012 Michael A Griffith, Director, bought 2,000 with an average share price of $4.88 per share and the total transaction amounting to $9,760.00.
  • On 9/21/2012 Glenn L Md Cooper, Director, bought 10,000 with an average share price of $6.09 per share and the total transaction amounting to $60,900.00.
  • On 5/15/2013 Walter C Herlihy, CEO, sold 40,000 with an average share price of $8.97 per share and the total transaction amounting to $358,800.00.
  • On 5/15/2013 Thomas F Ryan Jr, Director, sold 86,039 with an average share price of $9.01 per share and the total transaction amounting to $775,211.39.
  • On 5/17/2013 Thomas F Ryan Jr, Director, sold 21,000 with an average share price of $8.97 per share and the total transaction amounting to $188,370.00.
  • On 6/21/2013 Karen A Dawes, Director, bought 1,000 with an average share price of $7.70 per share and the total transaction amounting to $7,700.00.
  • On 8/8/2013 James R Rusche, SVP, sold 30,000 with an average share price of $10.01 per share and the total transaction amounting to $300,300.00.

    • Analyst Ratings History For Repligen (NASDAQ:RGEN)

      with a price target of $42.00 ➝ $47.00

    • On 7/21/2017 William Blair Initiated Coverage of rating Outperform ➝ Outperform
    • On 9/26/2017 Stephens Reiterated Rating Overweight with a price target of $50.00
    • On 10/2/2017 First Analysis Upgraded rating Equal Weight ➝ Overweight with a price target of $47.00
    • On 10/19/2017 Jefferies Group Reiterated Rating Hold with a price target of $40.00
    • On 11/13/2017 CL King Initiated Coverage of rating Buy ➝ Buy with a price target of $41.00
    • On 12/5/2017 JPMorgan Chase Initiated Coverage of rating Overweight ➝ Overweight with a price target of $42.00

    Recent Trading Activity for Repligen (NASDAQ:RGEN)
    Shares of Repligen closed the previous trading session at 42.64 up +0.58 1.38% with 42.099998474121094 shares trading hands.